Modified LIFT Versus Standard LIFT for Transsphincteric Anal Fistula
Modified LIFT Via a Lateral Approach Versus Standard LIFT for Transsphincteric Anal Fistula: A Prospective Randomized Study
1 other identifier
interventional
40
1 country
1
Brief Summary
This study evaluated two sphincter-preserving surgical techniques for transsphincteric anal fistula: standard ligation of the intersphincteric fistula tract (LIFT) and modified LIFT via a lateral approach. Adult patients with MRI-confirmed transsphincteric anal fistula were randomly assigned to one of the two procedures. The main outcome was wound healing time. Other outcomes included early recurrence or persistence of the fistula, postoperative pain, and fecal continence during 12 weeks of follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2024
CompletedFirst Submitted
Initial submission to the registry
May 18, 2026
CompletedFirst Posted
Study publicly available on registry
May 22, 2026
CompletedMay 26, 2026
May 1, 2026
4 months
May 18, 2026
May 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wound Healing Time
Time from surgery to complete clinical epithelialization of the perianal wound without discharge.
Up to 12 weeks after surgery
Secondary Outcomes (3)
Early Recurrence or Persistence of Anal Fistula
Postoperative weeks 1, 4, 8, and 12
Postoperative Pain Assessed Using the Visual Analog Scale
Postoperative weeks 1, 4, 8, and 12
Fecal Continence Assessed Using the Wexner Fecal Incontinence Score
Postoperative weeks 1, 4, 8, and 12
Study Arms (2)
Modified LIFT via a Lateral Approach
ACTIVE COMPARATORParticipants assigned to this arm underwent modified LIFT via a lateral approach. The fistula tract was approached from the external opening, dissected and mobilized toward the internal sphincter level, excised at this level, and the remaining defect and internal opening were closed while preserving sphincter integrity.
Standard LIFT
ACTIVE COMPARATORParticipants assigned to this arm underwent standard ligation of the intersphincteric fistula tract (LIFT). The intersphincteric plane was approached, and the fistula tract was identified, ligated, and divided according to the standard LIFT technique.
Interventions
Standard ligation of the intersphincteric fistula tract was performed. The intersphincteric plane was approached, and the fistula tract was identified, ligated, and divided according to the standard LIFT technique.
Modified LIFT via a lateral approach was performed. The fistula tract was approached from the external opening, dissected and mobilized toward the internal sphincter level, excised at that level, and the remaining defect and internal opening were closed.
Eligibility Criteria
You may qualify if:
- Age 18 to 75 years
- Diagnosis of transsphincteric anal fistula confirmed by pelvic magnetic resonance imaging
- Presence of clinical findings consistent with perianal fistula, such as perianal discharge, palpable swelling, or history of perianal abscess drainage
- Ability and willingness to provide written informed consent
- Eligibility for surgical treatment with either standard LIFT or modified LIFT via a lateral approach
You may not qualify if:
- Previous definitive surgery for perianal fistula other than abscess drainage
- Perianal Crohn disease
- Horseshoe fistula
- Colorectal cancer
- Malnutrition
- Recurrent anal fistula
- Previous radiotherapy or chemotherapy
- Chronic medication use that could impair wound healing, such as steroids or colchicine
- Refusal or inability to provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tugberk Toklead
Study Sites (1)
Kayseri City Training and Research Hospital
Kayseri, Kayseri, 38300, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tuğberk Tok, MD
Kayseri City Training and Research Hospital
- STUDY DIRECTOR
Yusuf Sevim, MD
Kayseri City Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- General Surgeon
Study Record Dates
First Submitted
May 18, 2026
First Posted
May 22, 2026
Study Start
January 1, 2024
Primary Completion
May 1, 2024
Study Completion
August 30, 2024
Last Updated
May 26, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be publicly shared due to ethical, institutional, and privacy restrictions. De-identified data may be available from the corresponding investigator upon reasonable request, subject to institutional approval.